The device, developed in the U.S. by the Michigan-based Renew Bioscience medical technology company, focuses on restoring ...

Terry Becker, a retired fifth-grade teacher from Lancaster County, Pennsylvania, says he feels he's experiencing positive ...

The treatment, lecanemab, has already been approved in some other countries, including the U.S., the U.K., Japan, Mexico and ...

Richard Oakley of the Alzheimer's Society spoke to Newsweek about why now is an "exciting time" in the battle against the ...

A new vitamin K-based treatment could help replenish lost neurons in Alzheimer's patients, offering hope for slowing ...

A new study is reviving hope that a twice-daily pill can slow down Alzheimer's in people whose genes put them at high risk ...

Scientists have repaired a natural gateway into the brains of mice, allowing the clumps and tangles associated with Alzheimer ...

Alzheimer’s disease is a progressive neurodegenerative disease that affects an individual’s behavior, memory, and mental capabilities. Alzheimer’s allows for the build-up of proteins in the brain, ...

Alzheimer’s Research UK said the new study “adds to the growing evidence that repairing the blood-brain barrier (BBB) itself could offer a new way to treat Alzheimer’s,” but added that it is too early ...

On Real Possibilities with AARP Michigan, associate professor of translational neuroscience Dr. Scott Counts from Michigan ...

Alzheimer's disease is a progressive neurological disorder characterised by memory loss and cognitive decline, caused by ...

The new treatment approach targets restoring normal blood vessel function instead of focusing on neurons or other brain cells, which has been the common strategy until now. A team of scientists co-led ...